Metabolic dysfunction and peroxisome proliferator-activated receptors (PPAR) in multiple sclerosis

Research output: Contribution to journalReview articlepeer-review

17 Citations (Scopus)

Abstract

Multiple sclerosis (MS) is an inflammatory and neurodegenerative disease of the central nervous system (CNS) probably caused, in most cases, by the interaction of genetic and environmental factors. This review first summarizes some clinical, epidemiological and pathological characteristics of MS. Then, the involvement of biochemical pathways is discussed in the development and repair of the CNS lesions and the immune dysfunction in the disease. Finally, the potential roles of peroxisome proliferator-activated receptors (PPAR) in MS are discussed. It is suggested that metabolic mechanisms modulated by PPAR provide a window to integrate the systemic and neurological events underlying the pathogenesis of the disease. In conclusion, the reviewed data highlight molecular avenues of understanding MS that may open new targets for improved therapies and preventive strategies for the disease.

Original languageEnglish
Article number1639
JournalInternational Journal of Molecular Sciences
Volume19
Issue number6
DOIs
Publication statusPublished - 1 Jun 2018

Keywords

  • Immune system
  • Metabolism
  • Multiple sclerosis
  • Neurodegeneration
  • Neuroinflammation
  • Peroxisome proliferator-activated receptors

Fingerprint

Dive into the research topics of 'Metabolic dysfunction and peroxisome proliferator-activated receptors (PPAR) in multiple sclerosis'. Together they form a unique fingerprint.

Cite this